Squamous Cell Carcinoma of the Oral Cavity in a Woman With a 9-Year History of Ovarian Cancer: Is Exposure to Pegylated Liposomal Doxorubicin a Factor?

Oncologist - United States
doi 10.1634/theoncologist.2013-0421
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Emerging Pharmacotherapies in Ovarian Cancer: Focus on Pegylated Liposomal Doxorubicin

Clinical Medicine Reviews in Women's Health
2010English

A Systematic Review and Economic Evaluation of Pegylated Liposomal Doxorubicin Hydrochloride for Ovarian Cancer

Health Technology Assessment
MedicineHealth Policy
2002English

Non‑pegylated Liposomal Doxorubicin for Patients With Recurrent Ovarian Cancer: A Multicentric Phase II Trial

Oncology Letters
Cancer ResearchOncology
2016English

A Retrospective Analysis of Pegylated Liposomal Doxorubicin in Ovarian Cancer: Do We Still Need It?

Journal of Ovarian Research
GynecologyOncologyObstetrics
2013English

Older Age Is a Risk Factor Associated With Poor Prognosis of Patients With Squamous Cell Carcinoma of the Oral Cavity

European Archives of Oto-Rhino-Laryngology
MedicineOtorhinolaryngology
2020English

A History of Allergies Is Associated With Reduced Risk of Oral Squamous Cell Carcinoma

Cancer Causes and Control
Cancer ResearchOncology
2012English

Oral Cavity Squamous Cell Carcinoma

2020English

Oral Contraceptives: A Risk Factor for Squamous Cell Carcinoma?

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2009English

Hepatocyte Nuclear Factor 4 Alpha Overexpression Confers Resistance to Radiation in a Human Oral Cavity Squamous Cell Carcinoma Cell Line

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy